Cristina R. Ferrone

26.9k total citations · 3 hit papers
300 papers, 11.3k citations indexed

About

Cristina R. Ferrone is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cristina R. Ferrone has authored 300 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 244 papers in Oncology, 134 papers in Surgery and 81 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cristina R. Ferrone's work include Pancreatic and Hepatic Oncology Research (186 papers), Neuroendocrine Tumor Research Advances (69 papers) and Pancreatitis Pathology and Treatment (62 papers). Cristina R. Ferrone is often cited by papers focused on Pancreatic and Hepatic Oncology Research (186 papers), Neuroendocrine Tumor Research Advances (69 papers) and Pancreatitis Pathology and Treatment (62 papers). Cristina R. Ferrone collaborates with scholars based in United States, Italy and Germany. Cristina R. Ferrone's co-authors include Carlos Fernández‐del Castillo, Andrew L. Warshaw, Keith D. Lillemoe, Sarah P. Thayer, Jennifer A. Wargo, Mari Mino–Kenudson, Vicente Morales‐Oyarvide, Vikram Deshpande, Theodore S. Hong and Dushyant V. Sahani and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Cristina R. Ferrone

288 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

2010 574 citations Andrea Boni, Alexandria P. Cogdill et al. Cancer Research profile →
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma

2018 362 citations Keith D. Lillemoe, Carlos Fernández‐del Castillo et al. profile →
Neoadjuvant therapy for pancreatic cancer

2023 199 citations Cristina R. Ferrone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cristina R. Ferrone United States	56	8.9k	5.5k	3.3k	2.6k	1.6k	300	11.3k
Ross A. Abrams United States	54	10.0k 1.1×	6.0k 1.1×	6.3k 1.9×	3.0k 1.2×	2.3k 1.4×	181	14.5k
Barish H. Edil United States	52	7.2k 0.8×	3.7k 0.7×	2.3k 0.7×	3.3k 1.3×	1.1k 0.7×	153	10.0k
Kenji Yamao Japan	53	8.6k 1.0×	8.1k 1.5×	4.3k 1.3×	2.7k 1.0×	1.0k 0.6×	286	12.0k
George A. Poultsides United States	54	5.7k 0.6×	4.8k 0.9×	4.3k 1.3×	1.9k 0.7×	1.3k 0.8×	397	10.1k
Howard Safran United States	47	5.7k 0.6×	2.7k 0.5×	3.9k 1.2×	1.2k 0.5×	1.5k 0.9×	229	9.2k
Theodore S. Hong United States	45	6.6k 0.7×	3.9k 0.7×	4.3k 1.3×	1.4k 0.6×	2.0k 1.3×	368	11.0k
Pascal Hammel France	65	12.1k 1.4×	5.7k 1.0×	3.6k 1.1×	5.8k 2.2×	2.9k 1.8×	367	15.8k
Jean‐Luc Van Laethem Belgium	44	7.9k 0.9×	3.4k 0.6×	3.2k 0.9×	1.6k 0.6×	2.2k 1.4×	275	10.4k
Daniel Castellano Spain	47	5.3k 0.6×	3.2k 0.6×	4.0k 1.2×	1.4k 0.5×	1.7k 1.1×	368	9.5k
Lisa Licitra Italy	63	8.1k 0.9×	5.9k 1.1×	4.3k 1.3×	1.4k 0.5×	1.4k 0.9×	447	16.0k

Countries citing papers authored by Cristina R. Ferrone

Since Specialization

Citations

This map shows the geographic impact of Cristina R. Ferrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina R. Ferrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina R. Ferrone more than expected).

Fields of papers citing papers by Cristina R. Ferrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina R. Ferrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina R. Ferrone. The network helps show where Cristina R. Ferrone may publish in the future.

Co-authorship network of co-authors of Cristina R. Ferrone

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina R. Ferrone. A scholar is included among the top collaborators of Cristina R. Ferrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina R. Ferrone. Cristina R. Ferrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qi, Ming, Giulia Cattaneo, Chiara Camillo, et al.. (2025). Pitfalls and strategies of CAR-T therapy in solid tumors and implications for chordoma treatment. Immunotherapy. 17(10). 1–13.

Shimizu, Takayuki, Jason M. Link, Arjun Verma, et al.. (2024). Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis. Surgery. 175(5). 1377–1385. 1 indexed citations

Malleo, Giuseppe, Gabriella Lionetto, Stefano Crippa, et al.. (2024). Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery. 282(6). 1092–1101. 3 indexed citations

Bolm, Louisa, Motaz Qadan, Nahel Elias, et al.. (2024). How to Predict Recurrence After Resection of Hepatocellular Carcinoma. Anticancer Research. 45(1). 189–199.

Fan, Jia, Tanios Bekaii‐Saab, Luca Aldrighetti, et al.. (2024). A phase 3, randomized study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01.. Journal of Clinical Oncology. 42(16_suppl). TPS4199–TPS4199. 4 indexed citations

Rickelt, Steffen, David T. Ting, Cristina R. Ferrone, et al.. (2024). β2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma. American Journal of Clinical Pathology. 162(5). 500–508. 1 indexed citations

Fong, Zhi Ven, Gabriella Lionetto, Louisa Bolm, et al.. (2023). 1178 LYMPH NODE YIELD IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL AND INCREASED TIME TO RECURRENCE IN NODE-NEGATIVE PANCREATIC DUCTAL ADENOCARCINOMA FOLLOWING NEOADJUVANT THERAPY. Gastroenterology. 164(6). S–1512.

Leonhardt, Carl-Stephan, Dietmar Pils, Gerd Jomrich, et al.. (2023). The Revised R Status Is an Independent Predictor of Postresection Survival in Pancreatic Cancer after Neoadjuvant Treatment. HPB. 25. S284–S285. 1 indexed citations

Cattaneo, Giulia, Jingyu Jia, Luke Maggs, et al.. (2023). 317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases. SHILAP Revista de lepidopterología. A360–A360. 1 indexed citations

10.

Neyaz, Azfar, Steffen Rickelt, Theodoros Michelakos, et al.. (2023). Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT). Histopathology. 83(4). 546–558. 6 indexed citations

11.

Fong, Zhi Ven, Jonathan A. Teinor, Lilly Engineer, et al.. (2023). Caregiver‐reported quality of communication in pancreatic and periampullary cancer. Cancer. 130(11). 2051–2059. 5 indexed citations

12.

Fong, Zhi Ven, Jonathan A. Teinor, Theresa P. Yeo, et al.. (2022). Assessment of Caregivers’ Burden When Caring for Patients With Pancreatic and Periampullary Cancer. JNCI Journal of the National Cancer Institute. 114(11). 1468–1475. 16 indexed citations

13.

Javed, Ammar A., Alessandra Pulvirenti, Jian Zheng, et al.. (2022). A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. Surgery. 172(6). 1800–1806. 7 indexed citations

14.

Maurer, Lydia R., Mohamad El Moheb, Donna Antonelli, et al.. (2021). Enhanced Recovery After Surgery Patients Are Prescribed Fewer Opioids at Discharge. Annals of Surgery. 277(2). e287–e293. 3 indexed citations

15.

Fong, Zhi Ven, David C. Chang, Chin Hur, et al.. (2020). Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer. The American Journal of Surgery. 220(1). 29–34. 19 indexed citations

16.

Shin, Christina H., Dustin R. Long, Duncan McLean, et al.. (2017). Effects of Intraoperative Fluid Management on Postoperative Outcomes. Annals of Surgery. 267(6). 1084–1092. 166 indexed citations

17.

Marra, Antonio, Cristina R. Ferrone, Giosuè Scognamiglio, et al.. (2017). Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives. Anti-Cancer Agents in Medicinal Chemistry. 18(2). 166–181. 11 indexed citations

18.

Perez, Numa P., David G. Forcione, & Cristina R. Ferrone. (2016). Late Pancreatic Fistula After Pancreaticoduodenectomy: A Case Report and Review of the Literature. PubMed. 2(1). 65–70. 2 indexed citations

19.

Boni, Andrea, Alexandria P. Cogdill, Ping Dang, et al.. (2010). Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function. Cancer Research. 70(13). 5213–5219. 574 indexed citations breakdown →

20.

Ferrone, Cristina R., Katherine S. Panageas, Klaus J. Busam, Mary Sue Brady, & Daniel G. Coit. (2002). Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status. Annals of Surgical Oncology. 9(7). 637–645. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact